Icure Pharmaceutical Inc.   Report issue

For profit Phase 3
Founded: Seoul Korea, Republic of (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2013
NCT01860625
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

donepezil (aricept) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1